FSA

Just how clear is the future for critical illness? Steve Casey outlines the factors contributing to the product's future.

In light of the FSA's proposed regulatory fee increases for IFAs, do you think that advisers should have more input with the regulator on rules affecting their business? Should they be represented on the board?

UK anti-corruption laws are tightening. Richard Burger explains their effects in the insurance arena.

Was the ban on payment protection insurance (PPI) sales by credit providers at the point at which credit is taken out a victory for consumers?

After much talk of a generic industry-wide protection campaign it seems the ball has started rolling. Paul Robertson explains the what it hopes to achieve and how it may impact the industry.

The FSA has published its RDR feedback statement. Will distinguishing between independent and sales advice, setting minimum qualifications for IFAs and introducing a standard for independent advice ‘reform the investment market' and increase confidence...

Is past claims performance a guide to the future or will the FOS work on transparency be valuable to the industry? Gill Salton asks.

The Insurance Conduct of Business (ICOB) sourcebook, which was supposed to be published on 6 December, has been delayed until further notice.